| Request A Trial | 
		
			| Product Overview Written for investors like you, FactSet’s proprietary news serves up essential, real-time market insights, 
				broadly spanning the U.S., Canada, Europe, and Asia-Pacific regions. Whether you’re tracking individual stocks, 
				monitoring sectors, or watching broader markets, FactSet StreetAccount provides simplified, actionable 
				summaries so you can skip past information overload and focus on the news that matters. Receive crucial 
				updates through your FactSet workstation, StreetAccount web, email, iOS application, or API—your access to 
				the news you need, when and where you need it.
 
 
 | 
        
            | Cut through the noise Institutional investors face the dual challenge of sifting 
				through overwhelming amounts of trivial data while struggling 
				to capture essential news. We’re doing the hard work for you —
				after our sophisticated system scans all possible news 
				sources, only the most material and market-moving content is 
				distilled and delivered to you. With StreetAccount, you’ll gain 
				timely, concise intelligence to keep a closer eye on the 
				companies and markets you care about.
 |   | 
        
			|   | Come for the coverage, stay for the service Eliminate the cumbersome work of monitoring news with our 
				highly filterable news alerts, sent straight to your inbox. With 
				succinct bullet-point summaries, you’ll quickly discover key 
				facts and crucial data from Earnings Previews, Conference Call 
				Guidance, and precise Street Takeaways that capture brokers' 
				reactions to major corporate events. We leave no stone 
				unturned—StreetAccount aims to find information from any 
				source that provides material news, including, but not limited 
				to press releases, SEC filings, government and regulatory 
				websites, U.S. Appeals Court rulings, prominent newspapers, 
				sell-side research notes, business networks, various X (Twitter) 
				accounts, and industry publications.
 | 
        
            | Rely on skillfully curated market insights Our expert team of former analysts, portfolio managers, 
				traders, and economists deliver content that's not only 
				relevant, but steeped in professional experience for maximum 
				value. We think like you to ensure every detail is thoroughly 
				scrutinized for deeper research capabilities and more 
				data-driven decision-making.
 |   | 
        
			|   | Keep up with corporate events Easily track and analyze crucial details from worldwide 
				company events using our comprehensive calendars. Quickly 
				see conference call dates, times, and dial-in information for 
				thousands of companies. Plus, you can view consensus versus 
				actual EPS/Sales figures and AI-generated transcript 
				summaries, all at your fingertips.
 | 
        
            | Get more with our AI With Transcript Intelligence via StreetAccount, you'll gain 
				access to full, LLM-generated earnings transcript summaries, 
				including Guidance, Q&A, and Key Themes. To ensure the 
				content is exactly what you need, our LLMs, curated by 
				experts, create AI-generated StreetAccount summaries that 
				are reviewed by those same experts—so you can spend less 
				time reading or listening to transcripts and have more time to 
				make the most confident decisions possible.
 |   | 
        
			|   | Enhance your pharmaceutical and biotech market intelligence With StreetAccount’s comprehensive drug database, you’ll dig 
				deep into the rapidly evolving industry of prescription drugs, 
				biologics, and pipeline candidates. Dive into detailed company 
				drug profiles categorized by branded, generic, and pipeline for 
				a more targeted analysis. Explore key data such as patent 
				expirations, drug-specific revenues, and upcoming industry 
				events. Gain a competitive edge with in-depth knowledge of 
				partnerships, competitors, and a listing of approved and 
				branded drugs for various indications. Filter your search by 
				upcoming drug events by type or clinical trial phase for 
				customized results.
 | 
		
			| What Clients Are Saying For 20 years, thousands of financial professionals have elevated their success with FactSet's real-time market intelligence.
 
 |